Clinical trial
Efficacy of Intralesional Bleomycin Alone and in Combination With Dexamethasone in Infantile Haemangiomas
NCT06080724 is registered in ClinicalTrials.gov with King Edward Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Intralesional Bleomycin Alone and in Combination With Dexamethasone in Infantile Haemangiomas
- Lead sponsor
- King Edward Medical University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 22, 2021
- Completion date
- March 20, 2022
- Enrollment
- 114 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
comparison of efficacy of sclerotherapy in infantile hemangioma